FDA label

What is travoprost used for?

The FDA-approved uses of travoprost, quoted from the Indications and Usage section of its DailyMed label.

Source: DailyMed SPL label file dated 2026-10-23. Publisher page

The FDA label says: “Travoprost ophthalmic solution (ionic buffered solution) 0.004% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.”

Run it in Rivvi

Which 2027 plans near you dropped or restricted travoprost?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Travoprost Ophthalmic Solution, solution/ drops

Indications and Usage, quoted from the label by Gland Pharma Limited (ANDA218159). Cross-references to other label sections are left out.

Travoprost ophthalmic solution (ionic buffered solution) 0.004% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Source: DailyMed label, set id 71c9ea95-f577-411a-8e22-819e44d9680e, version 4, effective December 2, 2025. NDC 68083-601, one of 10 listings for this product.

Questions

What is travoprost used for?

The FDA label says: “Travoprost ophthalmic solution (ionic buffered solution) 0.004% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.”

What drug class is travoprost?

FDA lists travoprost in the Prostaglandin Analog established pharmacologic class.

Does this page cover off-label uses or dosing?

No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.

More on Travoprost

Try it on your own data today.

Free to start. Most teams are using it the same day.